Abstract
Recently, we cloned the cDNA encoding the melanocyte lineage-specific antigen gp100 and demonstrated that gp100 is recognised by three different monoclonal antibodies (MAbs) used to diagnose malignant melanoma. In addition, we showed that tumour-infiltrating lymphocytes (TIL 1200) from a melanoma patient reacted specifically with cells transfected with the gp100 cDNA. Molecular characterisation of the gp100 cDNA revealed that the gp100 antigen is highly homologous, but not identical, to another melanocyte-specific protein, pMel17. Here, we report that cells transfected with pMel17 cDNA also react with all three MAbs used to diagnose malignant melanoma, NKI-beteb, HMB-45 and HMB-50. Moreover, pMel17 transfectants are specifically lysed by TIL1200. These data demonstrate that antigenic processing of both gp100 and pMel17 give rise to peptides seen by anti-melanoma cytotoxic T lymphocytes (CTL) and are therefore potential targets for immunotherapy of malignant melanoma.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adema, G., Bakker, A., de Boer, A. et al. pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br J Cancer 73, 1044–1048 (1996). https://doi.org/10.1038/bjc.1996.202
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.202
- Springer Nature Limited
This article is cited by
-
Modeling human gray hair by irradiation as a valuable tool to study aspects of tissue aging
GeroScience (2023)
-
Profiling mRNA of the Graying Human Hair Follicle Constitutes a Promising State-of-the-Art Tool to Assess Its Aging: An Exemplary Report
Journal of Investigative Dermatology (2013)
-
The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis
Scientific Reports (2012)
-
Primary Extrapulmonary Sugar Tumor (PEST): A Report of Four Cases
Modern Pathology (2001)